Leukapheresis Protocol - Clinical Trial
¿Cuál es el Propósito de este estudio?
We are doing this study to support vaccine development by studying blood cells of the immune system.
¿Cuál es la Condición que se está estudiando?
Testing leukapheresis fluid (cells) of the immune system to support vaccine development
¿Quién puede participar en el Estudio?
Adults who:
- Are ages 18 - 60
- Are in good health
- Do not have a bleeding disorder
- Are at least 110 pounds
- Do not have an autoimmune disease(s)
- Are not pregnant
- Have not had cancer within the past 5 years
- Are not currently in an investigational study
- Are not taking medications to treat high blood pressure
If you need assistance in understanding if you can participate, please contact Luis Ballón at 919-620-5334 or Darren Morrow at 919-684-6043.
Grupo etario
Adultos
¿Qué Implica?
If you choose to join this study, you will have 2 visits.
- You will have blood draws at both visits
- The first visit will measure safety labs
- The second visit will be 3 hours long for the leukapheresis procedure
Detalles del Estudio
Título Completo
EQA Proficiency Testing and Quality Control Leukapheresis Protocol
Investigador Principal
Número de Protocolo
IRB:
PRO00000873
Estado de inscripción
Abierto para inscripción